Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06528769
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
A Phase II Study of All-Trans Retinoic Acid ATRA and Cemiplimab in Patients With Advanced Leiomyosarcoma
Sponsor:
Organization:
None